Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Land Shark who wrote (1341859)	2/9/2022 5:24:50 PM
From: h_	1 Recommendation Recommended By maceng2 Read Replies (1) \| Respond to of 1573969

Sure, that's why it's been safely and effectively administered over four billion times to humans.

To: Land Shark who wrote (1341859)	2/9/2022 5:41:56 PM
From: h_	1 Recommendation Recommended By isopatch Read Replies (3) \| Respond to of 1573969

Your pubmed study is from July 2021, and if you understood science, you'd understand that it does not indicate that Ivermectin is ineffective for Covid. It states: "...we are uncertain about the efficacy and safety of ivermectin used to treat or prevent COVID-19." It has not disproven any hypothesis. Absence of evidence is not evidence of absence. Since that date, there have been studies showing efficacy, especially as prophylaxis and early treatment. Conducting a study on an early treatment drug by testing it at disease midpoint or later is rigging the science to get a desired "outcome."